Oncology & Cancer

Scientists find one-two punch for preclinical cancer models

A one-two punch of changing gene expression, then deploying immune checkpoint inhibitors, shows promise in battling one of the most treatment-resistant types of cancer in preclinical models, according to a new publication ...

page 7 from 13